A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
Clinical trial NCT04504032 · TERMINATED
Trial details
- NCT number
- NCT04504032
- Sponsor
- Gates Medical Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2021-03-10
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.